Probiotics for Gut Barrier Integrity
Certain strains reduce measured intestinal permeability in specific clinical settings, but barrier repair in general populations is largely unvalidated.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 10-20 billion CFU/day of a defined strain with barrier-function data, taken daily with food
- Expected timeframe
- 4-8 weeks
Protocol
- form
- Strains with barrier-relevant data include Lactobacillus rhamnosus GG, Lactobacillus plantarum 299v and Escherichia coli Nissle 1917. Strain designation matters - barrier effects are not a general probiotic property
- duration
- 4-8 weeks; barrier marker studies ran 4-12 weeks
- co factor
- Take with food. Evidence is mixed. Cell and animal studies show specific probiotic strains upregulate tight junction proteins including occludin and zonula occludens-1, increase mucin secretion and reduce paracellular permeability, and some human studies report reduced circulating zonulin, lipopolysaccharide-binding protein or improved lactulose-mannitol ratios with particular strains. But results vary substantially by strain and population, the measures themselves are contested - serum zonulin assays in particular have been shown to detect other proteins and correlate poorly with permeability - and clinical significance is unclear. Intestinal permeability is measurably increased in coeliac disease, Crohn disease and critical illness, but as a standalone diagnosis it is not established.
- titration
- Up to 20 billion CFU/day
- starting dose
- 10 billion CFU/day with a meal
Evidence
What the studies say
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg JZ, Yap C, Lytvyn L +4 more
Moderate certainty evidence suggests that probiotics are effective for preventing Clostridium difficile-associated diarrhea.
Safety
Caveats
Leaky gut as a standalone diagnosis is not medically recognised, and the tests sold for it - serum zonulin panels and food sensitivity IgG tests - are not validated; commercial zonulin assays have been shown to measure other proteins entirely. Increased intestinal permeability is real but occurs as a consequence of conditions such as coeliac disease, inflammatory bowel disease, NSAID use, alcohol excess and critical illness, so the productive approach is diagnosing and treating those. Persistent gut symptoms with weight loss, blood in stool, anaemia, nocturnal symptoms or a family history of bowel disease need investigation - coeliac disease must be tested for while still eating gluten, and inflammatory bowel disease requires specialist treatment. Safety: probiotics are live organisms and have caused bacteraemia and fungaemia; avoid in severe immunocompromise, critical illness, central venous catheters, short bowel syndrome and damaged heart valves unless specialist-advised - notably, critically ill patients are those with the most genuinely increased permeability and also those at greatest risk from probiotics, as the PROPATRIA pancreatitis trial demonstrated with increased mortality. Bloating and gas in the first week are common. In pregnancy, common Lactobacillus and Bifidobacterium strains are generally considered safe.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.